The increased expression of key regulatory genes, including GLUT1, PKM2, FASN, and SCD1, significantly promotes the growth and migration of colorectal cancer cells and enhances resistance to oxaliplatin [35]. The gene discussed is PKM; the disease is colorectal cancer.